CIRRX
Price
$17.43
Change
-$0.08 (-0.46%)
Updated
Oct 9 closing price
Net Assets
8.35B
IARYX
Price
$16.57
Change
-$0.06 (-0.36%)
Updated
Oct 9 closing price
Net Assets
690.34M
Interact to see
Advertisement

CIRRX vs IARYX

Header iconCIRRX vs IARYX Comparison
Open Charts CIRRX vs IARYXBanner chart's image
Cohen & Steers Real Estate Securities R
Price$17.43
Change-$0.08 (-0.46%)
VolumeN/A
Net Assets8.35B
Invesco Real Estate Y
Price$16.57
Change-$0.06 (-0.36%)
VolumeN/A
Net Assets690.34M
CIRRX vs IARYX Comparison Chart in %
View a ticker or compare two or three
VS
CIRRX vs. IARYX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIRRX is a Buy and IARYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIRRX has more cash in the bank: 8.35B vs. IARYX (690M). CIRRX pays higher dividends than IARYX: CIRRX (2.37) vs IARYX (2.17). CIRRX was incepted earlier than IARYX: CIRRX (11 years) vs IARYX (17 years). CIRRX (1.25) is less costly to investors than IARYX (1.13). IARYX is a more actively managed with annual turnover of: 63.00 vs. CIRRX (35.00). CIRRX has a lower initial minimum investment than IARYX: CIRRX (0) vs IARYX (1000). CIRRX annual gain was more profitable for investors over the last year : -2.89 vs. IARYX (-6.79). CIRRX return over 5 years is better than : 25.80 vs. IARYX (-0.40).
CIRRXIARYXCIRRX / IARYX
Total Expense Ratio1.251.13111%
Annual Report Gross Expense Ratio1.251.13111%
Fund Existence11 years17 years-
Gain YTD3.3580.1142,938%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.35B690M1,211%
Annual Yield % from dividends2.372.17109%
Returns for 1 year-2.89-6.7943%
Returns for 3 years32.517.63426%
Returns for 5 years25.80-0.40-6,378%
Returns for 10 years52.52-24.90-211%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NECCX14.82N/A
N/A
Natixis US Equity Opportunities C
JFNSX70.53N/A
N/A
Janus Henderson Global Life Sciences S
VMCPX398.15N/A
N/A
Vanguard Mid Cap Index InstitutionalPlus
BGLAX14.96N/A
N/A
Brookfield Global Listed InfrastructureA
BRWRX27.61-0.02
-0.07%
MFS Blended Research Growth Eq R1